Alyeska Investment Group’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-90,000
Closed -$3.96M 675
2022
Q1
$3.96M Buy
90,000
+75,000
+500% +$3.63M 0.04% 325
2021
Q4
$943K Buy
+15,000
New +$1.27M 0.01% 539
2020
Q1
Sell
-13,013
Closed -$541K 489
2019
Q4
$541K Buy
+13,013
New +$480K 0.01% 353
2019
Q3
Sell
-66,607
Closed -$2.32M 513
2019
Q2
$2.32M Buy
+66,607
New +$1.96M 0.03% 303
2018
Q4
Sell
-67,600
Closed -$1.32M 476
2018
Q3
$1.32M Buy
67,600
+58,840
+672% +$1.28M 0.01% 332
2018
Q2
$204K Sell
8,760
-5,214
-37% -$112K ﹤0.01% 441
2018
Q1
$298K Sell
13,974
-102,181
-88% -$2.32M ﹤0.01% 424
2017
Q4
$2.47M Buy
116,155
+16,155
+16% +$430K 0.02% 317
2017
Q3
$2.7M Buy
+100,000
New +$2.79M 0.02% 335

Other funds holding ZLAB

Alyeska Investment Group's ZLAB Position: Q2 2022 in Review

Alyeska Investment Group sold out of Zai Lab (ZLAB) in Q2 2022, closing a stake of 90,000 shares — an estimated $3.96M sold.

Alyeska Investment Group first reported a position in ZLAB in Q3 2017 and held it in 9 quarters. The position peaked at $3.96M in Q1 2022. 164 funds tracked by Wall St. Rank hold ZLAB as of Q2 2022.

  • Alyeska Investment Group reported no remaining Zai Lab position as of Q2 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 90,000 Zai Lab shares in Q2 2022, an estimated $3.96M.
  • Alyeska Investment Group first reported a position in Zai Lab in Q3 2017 and held it in 9 quarters.
  • Alyeska Investment Group's Zai Lab position peaked at $3.96M in Q1 2022.
  • 164 funds tracked by Wall St. Rank held Zai Lab as of Q2 2022.

Based on Alyeska Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.